Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226) |
---|
05/27/2004 | US20040102423 Spironolactone and angiotensin II antagonist combination therapy for treatment of congestive heart failure |
05/27/2004 | CA2765093A1 Bicyclic-substituted amines as histamine-3 receptor ligands |
05/27/2004 | CA2505819A1 Indolyl pyrazinone derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis |
05/27/2004 | CA2504737A1 Aromatic sulfone hydroxamic acids and their use as protease inhibitors |
05/27/2004 | CA2503993A1 Novel 2,3-dihydro-4(1h)-pyridinone derivatives, method for production thereof and pharmaceutical composition comprising the same |
05/27/2004 | CA2501932A1 Use of benzimidazole quinolinones for treating cancer |
05/26/2004 | EP1422218A1 Antiviral agent |
05/26/2004 | EP1421080A1 N-heterocyclyl substituted thienyloxy-pyrimidines used as herbicides |
05/26/2004 | EP1421079A1 Novel compounds |
05/26/2004 | EP1421078A1 Beta-3 adrenergic agonists |
05/26/2004 | EP1421077A2 Novel pyrazole analogs acting on cannabinoid receptors |
05/26/2004 | EP1421074A1 Novel compounds |
05/26/2004 | EP1421071A2 Substituted piperazine and diazepane derivaives as histamine h3 receptor modulators |
05/26/2004 | EP1420796A1 Androgen receptor modulators and methods of use thereof |
05/26/2004 | EP1420784A1 Compounds effecting glucokinase |
05/26/2004 | EP1420644A1 Substituted propargylamines |
05/26/2004 | EP1216245B1 Pharmaceutically active sulfonyl hydrazide derivatives |
05/26/2004 | EP1206474B1 Sulfonylphenylpyrazole compounds useful as cox-2 inhibitors |
05/26/2004 | EP1117661B1 Propanolamine derivatives substituted with heterocyclic compounds, methods for their production, pharmaceutical compositions containing said compounds and the use thereof |
05/26/2004 | EP1117642B1 Substituted 1,3-diaryl-2-pyridine-2-yl-3-(pyridine-2-ylamino)-propanol derivatives, methods for their production, pharmaceutical compositions containing the same and their use |
05/26/2004 | EP1027332B1 Novel lactam metalloprotease inhibitors |
05/26/2004 | CN1500087A 哒嗪酮醛糖还原酶抑制剂 Pyridazinone aldose reductase inhibitors |
05/26/2004 | CN1500086A Aminopiperidine derivatives |
05/26/2004 | CN1500082A Cyano-5ubstituted dihydropyrimidine compounds and their use to treat diseases |
05/26/2004 | CN1500081A Thiohydantonins and use thereof for treating diabetes |
05/26/2004 | CN1499970A Use of GAL3 receptor antagonists for treatment of. depression and/or anxiety and compounds useful in such methods |
05/26/2004 | CN1151148C Farnesy transferase inhibitors having pyrrole structure and process for preparation thereof |
05/26/2004 | CN1151147C Indole derivatives as 5-HT receptor antagonist |
05/26/2004 | CN1151138C Triazole antifungal agent |
05/26/2004 | CN1151133C Anthranilic acid amides and use thereof as medicaments |
05/26/2004 | CN1151127C Indole derivatives and their use in the treatment of malignant and other diseases caused by pathological cell proliferation |
05/25/2004 | US6740760 Such as 1-((s)-3-mercapto-2-methyl-propionyl)-(r)-pyrrol-idine-2-carboxylic acid for treating diseases associated with amyloidosis (alzheimer's disease, diabetes, and familial amyloid polyneuropathy) |
05/25/2004 | US6740682 Treatment of thrombotic diseases, asthma, emphysema, cirrhosis, arthritis, carcinoma, melanoma, restenois, atheroma, trauma, shock and reperfusion injury. |
05/25/2004 | US6740663 Mono- and di-fluorinated benzothiepine compounds as inhibitors of apical sodium co-dependent bile acid transport (ASBT) and taurocholate uptake |
05/25/2004 | US6740655 3',5'-cyclic nucleotide phosphodiesterase 4-specific inhibitors reduce eosinophil influx to the lungs; side effect reduction; antiinflammatory agent; antiallergens; respiratory system disorders, especially asthma |
05/25/2004 | CA2302058C A process for preparing 5-methoxy-4-methyl-2,4-dihydro-3h-1,2,4-triazol-3-one |
05/25/2004 | CA2115170C Imidazolyl-alkenoic acids |
05/21/2004 | WO2004041813A1 Compositions useful as inhibitors of rock and other protein kinases |
05/21/2004 | WO2004041789A1 Compositions useful as inhibitors of jak and other protein kinases |
05/21/2004 | WO2004041788A1 Novel pyrimidine-4,6-dicarboxamides for the selective inhibition of collagenases |
05/21/2004 | WO2004041784A1 Phenyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain or gastrointestinal disorders |
05/21/2004 | WO2004041782A1 Indoles useful in the treatment of androgen-receptor related diseases |
05/21/2004 | WO2004041780A2 N-(indole-2-carbonyl) amides as anti-diabetic agents |
05/21/2004 | WO2004041776A2 SULFONYLAMINOVALEROLAC TAMS AND DERIVATIVES THEREOF AS FACTOR Xa INHIBITORS |
05/21/2004 | WO2004041755A2 Quinazolinone compounds as calcilytics |
05/21/2004 | WO2004041282A1 Receptor regulator |
05/21/2004 | WO2004041209A2 Transcription factor modulating compounds and methods of use thereof |
05/21/2004 | WO2004041201A2 Benzofuran compounds, compositions and methods for treatment and prophylaxis of hepatitis c viral infections and associated diseases |
05/21/2004 | WO2004041161A2 Tetrahydropyranyl cyclopentyl benzylamide modulators of chemokine receptor activity |
05/21/2004 | WO2004018473A3 Azapurine derivatives |
05/21/2004 | WO2004014860A3 Fused heterocyclic compounds as peptidase inhibitors |
05/21/2004 | WO2004005406A3 Charge transport compositions on the basis of triarylmethanes and their use in electronic devices |
05/21/2004 | WO2004000817A3 Benzimidazole compounds and their use as estrogen agonists/antagonists |
05/21/2004 | CA2506772A1 Compositions useful as inhibitors of jak and other protein kinases |
05/21/2004 | CA2504805A1 Receptor regulator |
05/21/2004 | CA2504344A1 Benzofuran compounds, compositions and methods for treatment and prophylaxis of hepatitis c viral infections and associated diseases |
05/21/2004 | CA2504320A1 Compositions useful as inhibitors of rock and other protein kinases |
05/21/2004 | CA2503727A1 Anti-diabetic agents |
05/21/2004 | CA2502302A1 Quinazolinone compounds as calcilytics |
05/21/2004 | CA2502174A1 Tetrahydropyranyl cyclopentyl benzylamide modulators of chemokine receptor activity |
05/20/2004 | US20040097729 Substituted pyridine herbicides |
05/20/2004 | US20040097725 Charge transport compositions and electronic devices made with such compositions |
05/20/2004 | US20040097580 For therapy and prophylaxis of diseases or disorders induced by promotion of lipid peroxidation or accumulation of oxidized products |
05/20/2004 | US20040097579 Taxane formulations |
05/20/2004 | US20040097574 For therapy of inflammatory, allergic, or proliferative processes |
05/20/2004 | US20040097571 Imidazole compounds and their use as adenosine deaminase inhibitors |
05/20/2004 | US20040097570 Novel benzimidazole derivatives and pharmaceutical compositions comprising these compounds |
05/20/2004 | US20040097561 Benzamides and related inhibitors of factor Xa |
05/20/2004 | US20040097552 Cyanothiophene derivatives, compositions containing such compounds and methods of use |
05/20/2004 | US20040097547 For therapy of chemokine-mediated diseases such as acute and chronic inflammatory disorders and cancer |
05/20/2004 | US20040097545 Quinolinone derivatives |
05/20/2004 | US20040097518 For use in therapy and prophylaxis |
05/20/2004 | US20040097513 Novel non-imidazole compounds |
05/20/2004 | US20040097501 Triazole compounds useful as protein kinase inhibitors |
05/20/2004 | US20040097497 4-heteroaryl-3-heteroarylidenyl-2-indolinones and their use as protein kinase inhibitors |
05/20/2004 | US20040097496 Novel thiazine derivatives |
05/20/2004 | US20040097494 For use as nitric oxide synthase inhibitors |
05/20/2004 | US20040097487 To inhibits matrix metalloprotease activity |
05/20/2004 | US20040097483 Benzimidazole derivatives useful as histamine H3 antagonists |
05/20/2004 | US20040097471 For therapy and prophylaxis of influenza infection |
05/20/2004 | US20040097438 Fused-ring compounds and use thereof as drugs |
05/20/2004 | US20040094753 Photochromic compound exhibits absorption bands in two wavelength regions of 440 to 500 nm and 570 to 630 nm. |
05/19/2004 | EP1419152A1 Hiv inhibiting pyrimidines derivatives |
05/19/2004 | EP1418913A1 Substituted urea neuropeptide y y5 receptor antagonists |
05/19/2004 | EP1418906A1 Aminoalkyl-substituted aromatic bicyclic compounds, method for the production thereof and their use as medicaments |
05/19/2004 | EP1273575B1 Diazepane derivatives or salts thereof |
05/19/2004 | EP1086097B1 Sulfonylbenzene compounds as anti-inflammatory/analgesic agents |
05/19/2004 | EP1020453B1 6,7-asymmetrically disubstituted quinoxalinecarboxylic acid derivatives, addition salts thereof, and processes for the preparation of both |
05/19/2004 | DE10251019A1 New pyrimidine-4,6-dicarboxamide derivatives, are selective collagenase inhibitors useful e.g. for treating degenerative joint diseases, connective tissue disorders or cancer |
05/19/2004 | CN1498217A Heterocyclic compounds for aging-related and diabetic vascular complications |
05/19/2004 | CN1498209A 1-aryl-or 1-alkylsulfonylbenzazole derivatives as 5-hydroxytryptamine-6ligands |
05/19/2004 | CN1498205A Aryl and biaryl compounds having MCH modulatory activity |
05/19/2004 | CN1496987A Pyrazole derivative |
05/19/2004 | CN1496982A Imidazoline compound, its preparation method and drug composition containing them |
05/19/2004 | CN1496981A Cycloamine derivative and its use as medicine |
05/19/2004 | CN1150185C Propanolamine derivs. substd. with heteocyclic compound, methods for their production, pharmaceutical compositiions contg. said compounds and use thereof |
05/19/2004 | CN1150181C Substituted benzopyran analogs for treatment of inflammation |
05/19/2004 | CN1150180C Diarylbenzopyran derivatives as cycloosygenase-2 inhibitors |
05/19/2004 | CN1150178C Sidechain-bearing taxanes |
05/19/2004 | CN1150167C Indole derivatives |